Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2025-12-26 @ 8:43 AM
Study NCT ID:
NCT01010061
Status:
COMPLETED
Last Update Posted:
2018-09-14
First Post:
2009-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2012-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-23
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-06
First Submit QC Date:
None
Study First Post Date:
2009-11-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-12-02
Results First Submit QC Date:
None
Results First Post Date:
2014-04-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-15
Last Update Post Date:
2018-09-14
Last Update Post Date Type:
ACTUAL